Schedule 13D ownership disclosure

AKARI THERAPEUTICS PLC

Ordinary Shares, $0.000000005 par value · CUSIP: 00972G207

Event date: 2026-03-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ray Prudo, M.D.Reported CIK 0001653262

    Shares: 8,391,326,467.00 · Class: 8.9%

  • RPC Pharma Limited

    Shares: 800,766,600.00 · Class: 0.87%

  • Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company

    Shares: 38,709,600.00 · Class: 0.042%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-008880
Form type
SCHEDULE 13D/A
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Mar 04, 2026
Reporting period
Mar 02, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub